{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:30Z","timestamp":1759400970981},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vph.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T13:15:31Z","timestamp":1506172531000},"page":"45-52","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study"],"prefix":"10.1016","volume":"99","author":[{"given":"Miodrag","family":"Jani\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojca","family":"Lunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka","family":"France \u0160tiglic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Jerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Skitek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"\u010cerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janja","family":"Marc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorazd","family":"Dreven\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0161o","family":"\u0160abovi\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vph.2017.09.005_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.vph.2017.09.005_bb0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/138161209787315747","article-title":"Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system","volume":"15","author":"Jankowski","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.vph.2017.09.005_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0b013e31805751d3","article-title":"Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension","volume":"50","author":"Liu","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2017.09.005_bb0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2010.12.041","article-title":"Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males\u2014a pilot study","volume":"215","author":"Lunder","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.vph.2017.09.005_bb0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/1741826711423104","article-title":"Reduction of age-associated arterial wall changes by low-dose valsartan","volume":"19","author":"Lunder","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2017.09.005_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejim.2011.11.011","article-title":"The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial","volume":"23","author":"Lunder","year":"2012","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.vph.2017.09.005_bb0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/HCR.0000000000000027","article-title":"A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males","volume":"34","author":"Janic","year":"2014","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"issue":"2","key":"10.1016\/j.vph.2017.09.005_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/rej.2015.1722","article-title":"Low-dose fluvastatin and valsartan rejuvenate the arterial wall through telomerase activity increase in middle-aged men","volume":"19","author":"Janic","year":"2016","journal-title":"Rejuvenation Res."},{"issue":"1\u20133","key":"10.1016\/j.vph.2017.09.005_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2007.01.043","article-title":"The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts","volume":"561","author":"Kuhar","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2017.09.005_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3181\/00379727-90-21985","article-title":"Lactic dehydrogenase activity in blood","volume":"90","author":"Wroblewski","year":"1955","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.vph.2017.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2008.09.003","article-title":"Normothermic and hypothermic models for studying the deleterious effects of hypoxia-reoxygenation on EDHF-mediated relaxation in isolated porcine coronary arteries","volume":"59","author":"Ziberna","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.vph.2017.09.005_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/FJC.0000000000000393","article-title":"The \u201crise-peak-fall\u201d pattern of time dependency of the cardiovascular pleiotropic effects of treatment with low-dose atorvastatin, losartan, and a combination thereof in rats","volume":"68","author":"Janic","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2017.09.005_bb0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","article-title":"Clinical pharmacology of platelet cyclooxygenase inhibition","volume":"72","author":"Patrono","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2017.09.005_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","article-title":"Aspirin: the mechanism of action revisited in the context of pregnancy complications","volume":"8","author":"Cadavid","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2017.09.005_bb0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.0000254855.24394.f9","article-title":"Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects","volume":"27","author":"Yamamoto","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.vph.2017.09.005_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.fjc.0000179434.18750.28","article-title":"Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits","volume":"46","author":"Kato","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2017.09.005_bb0085","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1291\/hypres.31.1199","article-title":"Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits","volume":"31","author":"Imanishi","year":"2008","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.vph.2017.09.005_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1507\/endocrj.K10E-289","article-title":"Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients","volume":"58","author":"Kawagoe","year":"2011","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.vph.2017.09.005_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00380-012-0259-0","article-title":"Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta","volume":"28","author":"Lunder","year":"2013","journal-title":"Heart Vessel."},{"issue":"5","key":"10.1016\/j.vph.2017.09.005_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1479164113485102","article-title":"Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients","volume":"10","author":"Savic","year":"2013","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"3","key":"10.1016\/j.vph.2017.09.005_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jdiacomp.2016.12.002","article-title":"Impaired endothelial function and arterial stiffness in patients with type 2 diabetes - the effect of a very low-dose combination of fluvastatin and valsartan","volume":"31","author":"Boncelj Svetek","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.vph.2017.09.005_bb0110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.mehy.2013.03.028","article-title":"A new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged population","volume":"80","author":"Janic","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.vph.2017.09.005_bb0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1074248412463966","article-title":"Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas","volume":"18","author":"Lunder","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.vph.2017.09.005_bb0120","doi-asserted-by":"crossref","first-page":"BR366","DOI":"10.12659\/MSM.883347","article-title":"A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts","volume":"18","author":"Lunder","year":"2012","journal-title":"Med. Sci. Monit."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117301155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189117301155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T11:18:50Z","timestamp":1538738330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189117301155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"alternative-id":["S1537189117301155"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2017.09.005","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}